An Outpatient Study of the Efficacy of ARS-2 in Patients With Chronic Spontaneous Urticaria

​ Conditions: Urticaria Chronic

Interventions: Drug: Placebo; Drug: 0.5 mg epinephrine; Drug: 1 mg epinephrine

Sponsors: ARS Pharmaceuticals, Inc.

Not yet recruiting Conditions: Urticaria Chronic
Interventions: Drug: Placebo; Drug: 0.5 mg epinephrine; Drug: 1 mg epinephrine
Sponsors: ARS Pharmaceuticals, Inc.
Not yet recruiting